Order results by:
| Issue | Title | |
| Vol 5, No 2 (2013) | Current possibilities of therapy for sleep disorders in Parkinson’s disease | Abstract similar documents |
| Marina Romanovna Nodel | ||
| "... and awakening disorders in patients with Parkinson's disease (PD). It covers the current views of the role ..." | ||
| Vol 6, No 4 (2014) | The epidemiological, clinical, and genetic characteristics of Parkinson’s disease (in case of Zheleznogorsk) | Abstract similar documents |
| M. R. Sapronova, N. A. Shnaider | ||
| "... Parkinson’s disease (PD) is the second most common human neurodegenerative disorder. Genetically ..." | ||
| Vol 8, No 4 (2016) | HYPERSOMNIA AND CIRCADIAN DISTURBANCES IN PARKINSON’S DISEASE | Abstract similar documents |
| M. R. Nodel | ||
| "... studied symptoms of Parkinson’s disease (PD). It manifests as constant excessive sleepiness during the day ..." | ||
| Online-first | Features of pathogenesis and clinical manifestation of Parkinson's disease developed from essential tremor | Abstract similar documents |
| A. V. Kudrevatykh, I. V. Miliukhina | ||
| "... In last decades, there is evidence of the relationship of Parkinson's disease (PD) and essential ..." | ||
| Vol 4, No 2 (2012) | Capacities of the dopamine receptor agonist pramipexole in the treatment of patients with Parkinson’s disease | Abstract similar documents |
| S N Illarioshkin | ||
| "... receptor agonists (DRA) remains the leading pharmacotherapeutic strategy for Parkinson’s disease (PD ..." | ||
| Vol 4, No 3 (2012) | Clinical experience with requip modutab | Abstract similar documents |
| Denis Valeryevich Zakharov, V A Mikhailov | ||
| "... of therapy for extensive-stage Parkinson’s disease (PD) and to correct motor fluctuations and drug-induced ..." | ||
| Vol 5, No 1 (2013) | Dopamine dysregulation syndrome in Parkinson’s disease | Abstract similar documents |
| A V Nikitina, Natalia Vladimirovna Fedorova | ||
| "... therapy. According to the data available in the literature, DDS develops in 3-4% of the Parkinson’s ..." | ||
| Vol 5, No 1 (2013) | Practical aspects of the use of extended-release ropinirole (requip modutab) in the treatment of Parkinson’s disease | Abstract similar documents |
| Oleg Semenovich Levin, V K Datiyeva | ||
| "... receptor agonist (DRAs), which has been widely used to treat Parkinson’s disease (PD) in foreign countries ..." | ||
| Vol 5, No 2 (2013) | Neuropsychological syndromes in patients with Parkinson’s disease after deep electric stimulation of pallidar complex structures | Abstract similar documents |
| Yu V Mikadze, Irina Igorevna Titkova, A O Gushcha, V M Tyurnikov | ||
| "... The paper provides the results of neuropsychological examinations in 10 patients with Parkinson’s ..." | ||
| Vol 5, No 2 (2013) | The clinical picture of early-stage Parkinson’s disease. errors in the diagnosis of different forms | Abstract similar documents |
| E N Gubanova, Natalia Vladimirovna Fedorova | ||
| "... The paper describes the clinical picture of Parkinson’s disease (PD), by indicating its stages ..." | ||
| Vol 4, No 1 (2012) | Sustained-release pramipexole in the treatment of Parkinson’s disease | Abstract similar documents |
| Natalia Vladimirovna Fedorova | ||
| "... for dopaminergic deficiency in Parkinson’s disease (PD). Since 1996, pramipexole has been used to treat early ..." | ||
| Vol 9, No 4 (2017) | Sleep disorders in Parkinson’s disease: approaches to treatment and prevention | Abstract similar documents |
| M. R. Nodel, G. V. Kovrov | ||
| "... Nocturnal sleep disorders are one of the most important non-motor manifestations of Parkinson’s ..." | ||
| Vol 7, No 4 (2015) | Some aspects of treatment for cognitive impairments. Cyticolin: pharmacological characteristics, possible benefits, aspects of use | Abstract similar documents |
| N. V. Trofimova, I. S. Preobrazhenskaya | ||
| "... a positive effect on cognitive functions in patients with Alzheimer’s disease if it is used as an additional ..." | ||
| Vol 6, No 4 (2014) | Nondrug therapy in the combination rehabilitation of patients with Parkinson’s disease | Abstract similar documents |
| V. L. Golubev, A. B. Kamakinova | ||
| "... Non-drug rehabilitation in Parkinson’s disease (PD) has recently attracted the increasing ..." | ||
| Vol 4, No 3 (2012) | Current drug treatments for vestibular disorders | Abstract similar documents |
| Maksim Valeryevich Zamergrad | ||
| "... There has recently been significant progress in the treatment of different diseases accompanied ..." | ||
| Vol 3, No 1 (2011) | Sleep disorders in Parkinson's disease | Abstract similar documents |
| Marina Romanovna Nodel', Marina Romanovna Nodel | ||
| "... of Parkinson's disease (PD). Objective: to specify the clinical features of sleep disorders in patients with PD ..." | ||
| Vol 3, No 4 (2011) | Parkinson's disease fatigability and its correction with the dopamine receptor agonist pramipexole | Abstract similar documents |
| Marina Romanovna Nodel | ||
| "... Fatigability is a common nonmotor symptom in Parkinson's disease (PD), which worsens quality ..." | ||
| Vol 4, No 2 (2012) | Strokes in mitochondrial diseases | Abstract similar documents |
| N V Pizova | ||
| "... It is suggested that mitochondrial diseases might be identified in 22—33% of cryptogenic stroke ..." | ||
| Vol 5, No 3 (2013) | Role of anxiety and depressive disorders in the genesis of psychosomatic disorders | Abstract similar documents |
| Aleksandr Anatolyevich Shatenshtein | ||
| "... of psychosomatic diseases (coronary heart disease, hypertensive disease, duodenal ulcer disease, asthma ..." | ||
| Vol 1, No 3-4 (2009) | DEPRESSION AND CARDIOVASCULAR DISEASES | Abstract similar documents |
| Lyubov' Vladimirovna Romasenko, Lyubov Vladimirovna Romasenko | ||
| "... of a somatic disease in the genesis of developing symptomatic somatogenic and psychogenic mental disorders ..." | ||
| Vol 7, No 3 (2015) | Some clinical and diagnostic features of patients with new-onset epilepsy in the presence of chronic cerebrovascular disease | Abstract similar documents |
| D. R. Khasanova, T. V. Danilova, Z. K. Latypova | ||
| "... of chronic cerebrovascular disease. Patients and methods. A total of 304 patients (a study group of 174 ..." | ||
| Vol 10, No 1 (2018) | Chronic cerebrovascular diseases: pathogenetic mechanisms, clinical manifestations, and approaches to therapy | Abstract similar documents |
| N. V. Pizova | ||
| "... The paper gives data on the incidence of cerebrovascular diseases (CVD) and the pathogenetic ..." | ||
| Vol 11, No 2 (2019) | Pathogenesis, clinical features, and treatments of depression in Parkinson's disease | Abstract similar documents |
| I. V. Milyukhina | ||
| "... Depression is the most common non-motor manifestation of Parkinson's disease (PD), which ..." | ||
| Vol 4, No 2 (2012) | Clinical characteristics of multiple sclerosis in the Tomsk region | Abstract similar documents |
| V M Alifirova, M A Titova | ||
| "... moderate neurologic deficit and moderate disease progression. The women were observed to exhibit a more ..." | ||
| Vol 4, No 4 (2012) | Use of vitamin B 1 preparations with different solubility in fats/oils and aqueous media: Clinical and pharmacological aspects | Abstract similar documents |
| Galina Vladislavovna Ramenskaya, O A Petukhova, V V Smirnov | ||
| "... neurological diseases has been today registered on the Russian pharmaceutical market. The most used agents ..." | ||
| Vol 6, No 3 (2014) | Current therapy for Parkinson's disease | Abstract similar documents |
| A. V. Obukhova | ||
| "... The main goal of therapy for Parkinson's disease (PD) is to correct dopamine deficiency ..." | ||
| Vol 6, No 4 (2014) | The development and treatment of Alzheimer’s disease: Some genetic aspects | Abstract similar documents |
| I. S. Preobrazhenskaya, N. S. Snitskaya | ||
| "... The paper gives an update on the occurrence and development of Alzheimer’s disease (AD ..." | ||
| Vol 7, No 3 (2015) | Hereditary cerebellar ataxias with polyneuropathy | Abstract similar documents |
| Svetlana Vasilyevna Kopishinskaya | ||
| "... ataxias should be started by ruling out the hereditary nature of the disease, which is verified ..." | ||
| Vol 7, No 4 (2015) | Possibilities of using naftidrofuryl in the therapy of cerebrovascular diseases: Literature review and the authors’ observations | Abstract similar documents |
| A. N. Belova, D. N. Shakurova, E. V. Gayazova | ||
| "... The efficacy of naftidrofuryl in treating cerebrovascular diseases is analyzed on the basis ..." | ||
| Vol 9, No 1 (2017) | The clinical features, diagnosis, and treatment of cognitive impairments in Parkinson's disease | Abstract similar documents |
| G. N. Akhmadeeva, R. V. Magzhanov, G. N. Tayupova, A. R. Baitimerov | ||
| "... with Parkinson's disease (PD) and gives their characteristics and epidemiology, the specific features ..." | ||
| Vol 11, No 1 (2019) | Antidepressant therapy in patients with cardiovascular diseases | Abstract similar documents |
| V. E. Medvedev, E. A. Korovyakova, V. I. Frolova, E. V. Gushanskaya | ||
| "... Depression is the most common form of mental illness in patients with cardiovascular diseases (CVD ..." | ||
| Vol 1, No 2 (2009) | NERVOUS AND MENTAL DISORDERS OF PARKINSON'S DISEASE | Abstract similar documents |
| Marina Romanovna Nodel', N N Yakhno, Marina Romanovna Nodel, N N Yakhno | ||
| "... Parkinson's disease (PD) is a multisystemic neurodegenerative disease involving different mediator ..." | ||
| Vol 1, No 2 (2009) | DEPRESSION IN CEREBROVASCULAR DISEASES | Abstract similar documents |
| Tat'yana Gratsievna Voznesenskaya, Tatyana Gratsievna Voskresenskaya | ||
| "... The paper discusses the topical problem of depression in cerebrovascular diseases. It shows its ..." | ||
| Vol 3, No 1 (2011) | Meniere's disease | Abstract similar documents |
| Maksim Valer'evich Zamergrad, O A Mel'nikov, Maksim Valeryevich Zamergrad, O A Melnikov | ||
| "... Meniere's disease is one of the most common causes of recurrent vestibular vertigo. Despite its ..." | ||
| Vol 3, No 4 (2011) | New criteria for diagnosing Alzheimer's disease | Abstract similar documents |
| Andrei Yuryevich Emelin | ||
| "... Department of Nervous Diseases, S.M. Kirov Military Medical Academy, Saint Petersburg ..." | ||
| Vol 4, No 3 (2012) | Prevention and therapy of psychopathological disorders in patients with cardiovascular diseases | Abstract similar documents |
| Vladimir Ernstovich Medvedev | ||
| "... Psychopathological disorders in patients with cardiovascular diseases (CVD) are treated ..." | ||
| Vol 5, No 2 (2013) | Locomotor therapy with extended-release crystalline glucocorticoids | Abstract similar documents |
| Vladimir Vasilyevich Badokin | ||
| "... Topical glucocorticoid (GC) therapy for locomotor diseases is an extremely important component ..." | ||
| Vol 4, No 2S (2012): Сognitive and other neuropsychiatric disorders | Cognitive and neuropsychiatric disorders in extrapyramidal diseases | Abstract similar documents |
| O. S. Levin, M. A. Anikin, E. E. Vasenina | ||
| "... of Parkinson’s disease or Huntington’s disease in persons who are predisposed to these diseases. Moreover ..." | ||
| Vol 5, No 3 (2013) | Comorbidity of chronic pain and depression in neurological patients | Abstract similar documents |
| Gyuzel Rafkatovna Tabeeva | ||
| "... , the development of therapeutic resistance, and the risk of disease recurrence. The epidemiology and clinical ..." | ||
| Vol 2, No 1 (2010) | SUCCINIC ACID DERIVATIVES IN THERAPY FOR CEREBROVASCULAR DISEASE | Abstract similar documents |
| Natalia Vyacheslavovna Pizova | ||
| "... in different forms of cerebrovascular disease. The use of oxidants is stated to be one of the lines of therapy ..." | ||
| Vol 2, No 4 (2010) | Depression in Parkinson's disease | Abstract similar documents |
| Marina Romanovna Nodel', Marina Romanovna Nodel | ||
| "... Parkinson's disease (PD) is a multisystemic neurodegenerative disease with a wide spectrum ..." | ||
| Vol 4, No 1 (2012) | Sleep and awakening disorders in Parkinson’s disease: comprehensive approach to therapy | Abstract similar documents |
| Marina Romanovna Nodel | ||
| "... and awakening disorders in patients with Parkinson’s disease (PD). It covers the current views of the role ..." | ||
| Vol 6, No 1 (2014) | Apathy in Parkinson's disease patients | Abstract similar documents |
| M. R. Nodel | ||
| "... pathy in Parkinson's disease (PD) patients is one of the least studied manifestations of a broad ..." | ||
| Vol 6, No 2 (2014) | Therapeutic collaboration (compliance): Content of the definition, mechanisms of formation, and methods of optimization | Abstract similar documents |
| D.S. Danilov | ||
| "... diseases is discussed. Recommendations are given to improve its quality in cardiovascular, chronic ..." | ||
| Vol 7, No 1 (2015) | Vascular cognitive impairments in chronic kidney disease | Abstract similar documents |
| I. V. Rogova, V. V. Fomin, I. V. Damulin, E. G. Minakova, O. Yu. Selivanova, Yu. A. Petleva | ||
| "... kidney disease (CKD) and to assess an association of CIs with the signs of vascular wall remodeling ..." | ||
| Vol 8, No 2 (2016) | Vascular and neurodegenerative cognitive impairments: a clinical case report | Abstract similar documents |
| V. V. Zakharov, N. V. Vakhnina | ||
| "... patient management and disease prognosis. The paper describes a patient with moderate CI, with respect ..." | ||
| Vol 7, No 3 (2015) | Cognitive impairments in common and rare somatic diseases | Abstract similar documents |
| Natalia Vyacheslavovna Pizova | ||
| "... of cognitive impairments (CIs) in different autoimmune, endocrine, and infectious diseases, such as systemic ..." | ||
| Vol 7, No 3 (2015) | Experience in using levodopa-benserazide | Abstract similar documents |
| Elena Anatolyevna Katunina, Yu. N. Bezdolnyi, E. A. Malykhina, N. V. Titova | ||
| "... Levodopa remains the most effective drug for the treatment of Parkinson's disease. The paper ..." | ||
| Vol 8, No 1 (2016) | Role of lipoprotein (a) in the development of ischemic stroke and other cardiovascular diseases | Abstract similar documents |
| N. A. Pizov, N. V. Pizova | ||
| "... lipoprotein (a) (Lp (a)) in the development of ischemic stroke and other cardiovascular diseases. It shows ..." | ||
| Vol 7, No 2 (2015) | Cognitive impairments in some cardiovascular and somatic diseases | Abstract similar documents |
| N. V. Pizova | ||
| "... of cognitive impairments (CIs) in different autoimmune, endocrine, and infectious diseases: systemic lupus ..." | ||
| 1 - 50 of 145 Items | 1 2 3 > >> | |
Search tips:
- Search terms are case-insensitive
- Common words are ignored
- By default articles containing any term in the query are returned (i.e., OR is implied)
- Make sure that a word exists in an article by prefixing it with +; e.g., +journal +access scholarly academic
- Combine multiple words with AND to find articles containing all terms; e.g., education AND research
- Exclude a word by prefixing it with - or NOT; e.g., online -politics or online NOT politics
- Search for an exact phrase by putting it in quotes; e.g., "open access publishing". Hint: Quoting Chinese or Japanese words will help you to find exact word matches in mixed-language fields, e.g. "中国".
- Use parentheses to create more complex queries; e.g., archive ((journal AND conference) NOT theses)
